Clinical Trial Update: Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics

View source ↗

Summary

This clinical trial update reports a secondary data analysis of patients at risk for chronic kidney disease to examine CKD prevalence, diagnosis rates, diagnost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Diseases | Status: COMPLETED